Table 1.
Variables Mean (SD) |
Total sample (n = 17) | Exercise group (n = 9) | Control group (n = 8) |
---|---|---|---|
Age (year) | 67 (9) | 66 (10) | 68 (9) |
Height (cm) | 165 (12) | 164 (14) | 166 (11) |
Weight (kg) | 72 (21) | 67 (14) | 77 (27) |
BMI (kg m−2) | 26 (6) | 25 (5) | 27 (6) |
Smoking (pack years) | 35 (15) | 49 (27) | 35 (24) |
FEV1 (L) | 1.65 (0.49) | 1.53 (0.47) | 1.78 (0.50) |
FEV1 (%pred) | 66 (17) | 61 (17) | 71 (15) |
FVC (L) | 2.68 (0.69) | 2.51 (0.76) | 2.87 (0.58) |
FVC (%pred) | 80 (12) | 74 (11) | 86 (10) |
FEV1/FVC (%) | 62 (12) | 62 (14) | 62 (11) |
TLC (L) | 4.73 (1.19) | 4.58 (1.56) | 4.91 (0.64) |
TLC (%pred) | 86 (14) | 82 (16) | 90 (12) |
FRC (L) | 2.94 (0.78) | 2.87 (1.00) | 3.02 (0.47) |
FRC (%pred) | 97 (20) | 94 (20) | 100 (21) |
DLCO (mL min−1 mmHg−1) | 13.7 (3.6) | 12.8 (3.3) | 14.7 (3.8) |
DLCO (%pred) | 53 (12) | 49 (11) | 57 (13) |
MVV (L min−1) | 62 (21) | 60 (25) | 64 (28) |
MVV (%pred) | 63 (16) | 59 (15) | 67 (18) |
n | % | n | % | n | % | |
---|---|---|---|---|---|---|
Gender, male/female | 5/12 | 29/71 | 3/6 | 30/70 | 2/6 | 25/75 |
COPD | 9 | 53 | 5 | 56 | 4 | 50 |
Type of NSCLC | ||||||
Adenocarcinoma | 10 | 59 | 5 | 56 | 5 | 63 |
Squamous cell carcinoma | 6 | 35 | 4 | 44 | 2 | 25 |
Large cell carcinoma | 1 | 6 | 0 | 0 | 1 | 12 |
NSCLC stage | ||||||
I | 14 | 82 | 7 | 78 | 7 | 88 |
II | 2 | 12 | 2 | 22 | 0 | 0 |
IIIA | 1 | 6 | 0 | 0 | 1 | 12 |
Types of surgery | ||||||
Open | 8 | 47 | 4 | 44 | 4 | 50 |
VATS | 9 | 53 | 5 | 56 | 4 | 50 |
Adjuvant chemotherapy | 2 | 12 | 1 | 11 | 1 | 12 |
BMI, body-mass index; COPD, chronic obstructive pulmonary disease; DLCO, single breath diffusing capacity for carbon monoxide; FEV1, forced expiratory volume in one second; FRC, functional residual capacity; FVC, forced vital capacity; MVV, maximum voluntary ventilation; NSCLC, non-small cell lung cancer; SD, standard deviation; TLC, total lung capacity; VATS, video-assisted thoracoscopic surgery.